{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:34:22Z","timestamp":1784140462049,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Historically, psoriasis (Pso) and atopic dermatitis (AD) were considered mutually exclusive diseases due to their activation of opposing immune pathways\u2014Th17 in Pso and Th2 in AD. However, growing clinical evidence and systematic reviews have challenged this dichotomy, demonstrating that both conditions can coexist in the same individual. This paper aims to provide an overview of the nomenclature, epidemiology, genetics, pathogenesis, and clinical features of coexistent psoriasis and atopic dermatitis, whether drug-induced or not. These conditions are also collectively referred to as \u201cPsoDermatitis\u201d.<\/jats:p>","DOI":"10.3390\/jcm15010130","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:22:27Z","timestamp":1766578947000},"page":"130","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unravelling the Mystery of Psoriasis Dermatitis (PsoDermatitis): A Practical Guide to Recognition and Management"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0885-054X","authenticated-orcid":false,"given":"Riccardo","family":"Balestri","sequence":"first","affiliation":[{"name":"Division of Dermatology, Psoriasis Outpatient Service, Azienda Sanitaria Integrata del Trentino (ASUIT)\u2014Trento Hospital, 38122 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9429-9004","authenticated-orcid":false,"given":"Michela","family":"Magnano","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, Lucca Hospital, Azienda USL Toscana Nord Ovest, Via Guglielmo Lippi Francesconi 556, 55100 Lucca, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Domenico","family":"Infusino","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Psoriasis Outpatient Service, Azienda Sanitaria Integrata del Trentino (ASUIT)\u2014Trento Hospital, 38122 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Ioris","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Psoriasis Outpatient Service, Azienda Sanitaria Integrata del Trentino (ASUIT)\u2014Trento Hospital, 38122 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Lacava","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Psoriasis Outpatient Service, Azienda Sanitaria Integrata del Trentino (ASUIT)\u2014Trento Hospital, 38122 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Rene","family":"Girardelli","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Psoriasis Outpatient Service, Azienda Sanitaria Integrata del Trentino (ASUIT)\u2014Trento Hospital, 38122 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rech","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Psoriasis Outpatient Service, Azienda Sanitaria Integrata del Trentino (ASUIT)\u2014Trento Hospital, 38122 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/09546634.2019.1702147","article-title":"Concomitant atopic dermatitis and psoriasis\u2014A retrospective review","volume":"32","author":"Barry","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1540-9740.2005.03636.x","article-title":"PsEma\u2014A hitherto unnamed dermatologic entity with clinical features of both psoriasis and eczema","volume":"4","author":"Abramovits","year":"2005","journal-title":"SKINmed Dermatol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e13498","DOI":"10.1111\/dth.13498","article-title":"Long-term safety of combined biological therapy in a patient affected by arthropathic psoriasis and atopic dermatitis","volume":"33","author":"Balestri","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1002\/ski2.29","article-title":"Can atopic eczema and psoriasis coexist? A systematic review and meta-analysis","volume":"1","author":"Cunliffe","year":"2021","journal-title":"Skin Health Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000514581","article-title":"Bidirectional Association between Psoriasis and Atopic Dermatitis: A Nationwide Population-Based Cohort Study","volume":"237","author":"Dai","year":"2021","journal-title":"Dermatology"},{"key":"ref_7","first-page":"2506","article-title":"Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy","volume":"30","author":"Mangge","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_8","first-page":"315","article-title":"Counter-regulatory balance: Atopic dermatitis in patients undergoing infliximab infusion therapy","volume":"3","author":"Chan","year":"2004","journal-title":"J. Drugs Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09546634.2016.1230173","article-title":"Eczema as an adverse effect of anti-TNF\u03b1 therapy in psoriasis and other Th1-mediated diseases: A review","volume":"28","author":"Nakamura","year":"2017","journal-title":"J. Dermatolog Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jdv.16246","article-title":"Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: A systematic review","volume":"34","author":"Foulkes","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"BADBIR Study Group. Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis","volume":"160","author":"Alabas","year":"2024","journal-title":"JAMA Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1111\/jdv.17050","article-title":"for GREAT Research Group. De novo psoriasis in atopic dermatitis patients treated with dupilumab: A retrospective cohort","volume":"35","author":"Jaulent","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13142","DOI":"10.1111\/dth.13142","article-title":"Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series","volume":"32","author":"Napolitano","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13555-021-00505-z","article-title":"Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre","volume":"11","author":"Napolitano","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","article-title":"The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017","volume":"84","author":"Mehrmal","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/ajd.13846","article-title":"Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis","volume":"63","author":"Casale","year":"2022","journal-title":"Australas. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000530608","article-title":"Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review","volume":"239","author":"Su","year":"2023","journal-title":"Dermatology"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tsai, Y.C., and Tsai, T.F. (2022). Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105518"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic Dermatitis Is an IL-13-Dominant Disease with Greater Molecular Heterogeneity Compared to Psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/86867","article-title":"Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci","volume":"27","author":"Cookson","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dong, S., Li, D., and Shi, D. (2024). Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1335551"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","article-title":"Atopic dermatitis and psoriasis: Two different immune diseases or one spectrum?","volume":"48","author":"Krueger","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/all.15921","article-title":"Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the \u201cFlip-Flop\u201d phenomenon)","volume":"79","author":"Welchowski","year":"2024","journal-title":"Allergy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/bjd.16126","article-title":"Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics","volume":"178","author":"Stoffel","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-019-00742-7","article-title":"T cell pathology in skin inflammation","volume":"41","author":"Sabat","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1104200","article-title":"Mutual antagonism of T cells causing psoriasis and atopic eczema","volume":"365","author":"Eyerich","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jdcr.2017.11.026","article-title":"Concurrence of psoriasis vulgaris and atopic eczema in a single patient exhibiting different expression patterns of psoriatic autoantigens in the lesional skin","volume":"4","author":"Ono","year":"2018","journal-title":"JAAD Case Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1398-9995.2006.01058.x","article-title":"Adverse side-effects to biological agents","volume":"61","author":"Pichler","year":"2006","journal-title":"Allergy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","article-title":"Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E","volume":"35","author":"Chang","year":"2011","journal-title":"Immunity"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jid.2018.01.036","article-title":"Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis","volume":"138","author":"Vandeghinste","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","first-page":"e40","article-title":"Paradoxical eczematous reaction to ixekizumab","volume":"33","author":"Ballesca","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bjd.17779","article-title":"Eczematous eruption during anti-interleukin 17 treatment of psoriasis: An emerging condition","volume":"181","author":"Napolitano","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e15255","DOI":"10.1111\/dth.15255","article-title":"Dupilumab-induced psoriasis in a patient with atopic dermatitis and alopecia totalis: A case report and literature review","volume":"35","author":"Flanagan","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ali, K., Wu, L., Qiu, Y., and Li, M. (2022). Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab. Front. Med., 9.","DOI":"10.3389\/fmed.2022.932766"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1346-8138.13762","article-title":"Cutaneous side-effects of biologics in immune-mediated disorders: A histopathological perspective","volume":"44","author":"Succaria","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/14712598.2020.1727439","article-title":"Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: A case series and review of the literature","volume":"20","author":"Caldarola","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"de Felici Del Giudice, M.B., Ravaglia, G., Brusasco, M., and Satolli, F. (2025). Managing the Overlap: Therapeutic Approaches in Patients with Concomitant Psoriasis and Atopic Dermatitis-A Case Series. J. Clin. Med., 14.","DOI":"10.3390\/jcm14030796"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","article-title":"Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis","volume":"384","author":"McInnes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_39","first-page":"312","article-title":"Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2","volume":"80","author":"Mease","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ced.15104","article-title":"Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib","volume":"47","author":"Ferrucci","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13555-022-00851-6","article-title":"The Combination of Dupilumab with Other Monoclonal Antibodies","volume":"13","author":"Gisondi","year":"2023","journal-title":"Dermatol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ijd.17397","article-title":"Tralokinumab-induced psoriasis relapse in a patient with atopic dermatitis","volume":"64","author":"Tavoletti","year":"2025","journal-title":"Int. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.alit.2021.07.003","article-title":"Subtypes of atopic dermatitis: From phenotype to endotype","volume":"71","author":"Tokura","year":"2022","journal-title":"Allergol. Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/130\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:42:35Z","timestamp":1766580155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010130"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010130","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}